Aspen Pharmacare Holdings Limited (JSE:APN)
14,474
+999 (7.41%)
May 29, 2026, 5:00 PM SAST
Aspen Pharmacare Holdings Ratios and Metrics
Market cap in millions ZAR. Fiscal year is July - June.
Millions ZAR. Fiscal year is Jul - Jun.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | May '26 May 29, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
| 64,268 | 53,079 | 103,810 | 81,701 | 62,047 | 73,836 | |
Market Cap Growth | 20.28% | -48.87% | 27.06% | 31.68% | -15.97% | 12.88% |
Enterprise Value | 91,591 | 81,746 | 128,328 | 100,452 | 81,357 | 101,518 |
Last Close Price | 144.74 | 116.89 | 224.02 | 172.83 | 127.83 | 147.38 |
PE Ratio | - | - | 23.57 | 15.63 | 9.56 | 15.36 |
Forward PE | 16.01 | 9.58 | 12.68 | 10.44 | 7.34 | 11.63 |
PS Ratio | 1.51 | 1.22 | 2.32 | 2.01 | 1.61 | 1.96 |
PB Ratio | 0.79 | 0.63 | 1.22 | 0.95 | 0.88 | 1.13 |
P/TBV Ratio | 1.91 | 3.71 | 7.46 | 4.45 | 4.68 | 9.88 |
P/FCF Ratio | 14.53 | 20.55 | 33.40 | 24.83 | 18.19 | 15.45 |
P/OCF Ratio | 9.27 | 10.29 | 16.68 | 14.80 | 11.55 | 10.82 |
PEG Ratio | 1.47 | 0.90 | 0.89 | 0.66 | 0.46 | 1.27 |
EV/Sales Ratio | 2.15 | 1.89 | 2.87 | 2.47 | 2.11 | 2.69 |
EV/EBITDA Ratio | 11.68 | 9.60 | 12.49 | 9.86 | 8.19 | 11.06 |
EV/EBIT Ratio | 15.16 | 11.69 | 14.47 | 11.25 | 9.31 | 12.52 |
EV/FCF Ratio | 20.70 | 31.65 | 41.29 | 30.53 | 23.85 | 21.24 |
Debt / Equity Ratio | 0.41 | 0.43 | 0.43 | 0.34 | 0.31 | 0.38 |
Debt / EBITDA Ratio | 4.20 | 4.13 | 3.47 | 2.82 | 2.20 | 2.66 |
Debt / FCF Ratio | 7.45 | 13.98 | 11.73 | 8.90 | 6.52 | 5.21 |
Net Debt / Equity Ratio | 0.34 | 0.35 | 0.28 | 0.21 | 0.23 | 0.25 |
Net Debt / EBITDA Ratio | 3.59 | 3.49 | 2.35 | 1.80 | 1.62 | 1.78 |
Net Debt / FCF Ratio | 6.18 | 11.50 | 7.76 | 5.58 | 4.71 | 3.42 |
Asset Turnover | 0.32 | 0.32 | 0.33 | 0.33 | 0.35 | 0.31 |
Inventory Turnover | 1.42 | 1.35 | 1.35 | 1.24 | 1.40 | 1.34 |
Quick Ratio | 1.03 | 1.17 | 1.06 | 1.06 | 0.79 | 0.52 |
Current Ratio | 3.64 | 2.21 | 1.81 | 1.92 | 1.48 | 0.89 |
Return on Equity (ROE) | -2.17% | -1.28% | 5.15% | 6.65% | 9.50% | 7.12% |
Return on Assets (ROA) | 2.85% | 3.18% | 4.06% | 4.54% | 4.94% | 4.17% |
Return on Invested Capital (ROIC) | 5.57% | 6.26% | 6.40% | 7.43% | 8.25% | 6.97% |
Return on Capital Employed (ROCE) | 5.40% | 5.90% | 7.70% | 8.00% | 9.90% | 11.10% |
Earnings Yield | -3.11% | -2.04% | 4.24% | 6.40% | 10.46% | 6.51% |
FCF Yield | 6.88% | 4.87% | 2.99% | 4.03% | 5.50% | 6.47% |
Dividend Yield | 1.46% | 1.80% | 1.60% | 1.98% | 2.55% | 1.78% |
Payout Ratio | - | - | 34.63% | 27.83% | 18.43% | - |
Buyback Yield / Dilution | -0.03% | 0.04% | - | 1.94% | 0.77% | - |
Total Shareholder Return | 1.53% | 1.85% | 1.60% | 3.92% | 3.32% | 1.78% |